½ÃÀ庸°í¼­
»óǰÄÚµå
1530240

ȯÀÚ Ãø¸é À̵¿ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : À¯Çüº°, »ç¿ëº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Patient Lateral Transfer Market Size, Share & Trends Analysis Report By Type (Air-assisted Transfer Mattress), By Usage (Reusable, Disposable), By End Use (Hospitals, ASC¢¥s), By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 120 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ȯÀÚ Ãø¸é À̵¿ ½ÃÀå ±Ô¸ð¿Í µ¿Çâ

ȯÀÚ Ãø¸é À̵¿ ¼¼°è ½ÃÀå ±Ô¸ð´Â 2023³â 4¾ï 1,240¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 9.1%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ½ÃÀåÀº ¿©·¯ ¿äÀÎÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¸¸¼º Áúȯ°ú Àå¾ÖÀÇ À¯º´·ü Áõ°¡°¡ ¼ö¿ä¸¦ ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ Çõ½ÅÀûÀÎ ÀÌ¼Û µµ±¸°¡ °³¹ßµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ȯÀÚ¸¦ ¾ÈÀüÇÏ°Ô Ãë±ÞÇÏ´Â ¹æ¹ýÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾ö°ÝÇÑ ±ÔÁ¦·Î ÀÎÇØ ÀÇ·á ȯ°æ¿¡¼­´Â ÀûÀýÇÑ ÀÌ¼Û ÀåºñÀÇ »ç¿ëÀÌ Àǹ«È­µÇ¾î ÀÖ½À´Ï´Ù.

¸¸¼º Áúȯ°ú ½Åü Àå¾Ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó È¿À²ÀûÀΠȯÀÚ ÀÌ¼Û ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ºñ¸¸, ±Ù°ñ°Ý°è Áúȯ, ½Å°æ Àå¾Ö¿Í °°Àº ÁúȯÀº ¾ÈÀüÇÏ°í Æí¾ÈÇÑ Ãø¸é À̵¿À» À§ÇØ Æ¯¼ö Àåºñ°¡ ÇÊ¿äÇÑ °æ¿ì°¡ ¸¹½À´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 3¿ù ¼¼°èº¸°Ç±â±¸(WHO)´Â 2022³â ±âÁØ Àü ¼¼°è Àα¸ 8¸í Áß 1¸íÀÌ ºñ¸¸°ú °øÁ¸Çϰí ÀÖ´Ù°í º¸°íÇß½À´Ï´Ù. ¶ÇÇÑ, 18¼¼ ÀÌ»ó ¼ºÀÎ 25¾ï ¸í Áß 8¾ï 9,000¸¸ ¸íÀÌ ºñ¸¸ Áø´ÜÀ» ¹Þ¾Ò½À´Ï´Ù. ÀÌ·¯ÇÑ ¸¸¼ºÁúȯÀÇ Áõ°¡´Â ȯÀÚÀÇ Æí¾ÈÇÔ°ú °£º´ÀÎÀÇ ¾ÈÀüÀ» ¸ðµÎ º¸ÀåÇÒ ¼ö ÀÖ´Â À̵¿ º¸Á¶±â±¸¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº È¿À²À» ³ôÀ̰í ÀÌ¼Û Áß ºÎ»ó À§ÇèÀ» ÁÙÀÌ´Â Á¤±³ÇÑ ÀÌ¼Û ÀåºñÀÇ ½ÃÀå °³Ã´À» °¡´ÉÇÏ°Ô ÇÏ¿© ȯÀÚ ÀÌ¼Û ½ÃÀå¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ¿¡¾î ¾î½Ã½ºÆ® Ãø¸é À̵¿ ½Ã½ºÅÛ, ½½¶óÀ̵ù ½ÃÆ®, ±â°è½Ä ¸®ÇÁÆ®¿Í °°Àº Àåºñ´Â ȯÀÚ À̵¿ÀÇ ¿ëÀ̼º°ú ¾ÈÀü¼ºÀ» Å©°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÀÇ·á ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϰí ȯÀÚ Ä¡·á °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ±â¿©Çϰí ÀÖÀ¸¸ç, 2022³â 3¿ù, Sage´Â ¼ö¼ú½Ç¿ë »õ·Î¿î À̵¿½Ä °ø±â ÀÌ¼Û ½Ã½ºÅÛÀÎ ¸ÖƼ Æ÷Áö¼Ç MATS¸¦ Ãâ½ÃÇÏ¿´½À´Ï´Ù. ÀÌ Àåºñ´Â ¼ö¼ú½Ç °£È£»ç°¡ ȯÀÚ¸¦ ¾ÈÀüÇÏ°Ô ¹èÄ¡Çϰí À̼ÛÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÖ¸ç, ¸®¼ÒÅä¹Ì, Æ®·»µ¨·»ºÎ¸£Å©¿Í °°Àº Áß¿äÇÑ °æ»ç ÀÚ¼¼¿¡¼­ ½½¶óÀ̵ù ¹× ºÎ»ó À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù.

ÀÇ·á ¼­ºñ½º Á¦°øÀÚµéÀº °£º´ÀÎÀÇ ±Ù°ñ°Ý°è ¼Õ»óÀ» ¿¹¹æÇϰí ÃÖÀûÀÇ È¯ÀÚ Ä¡·á¸¦ º¸ÀåÇϱâ À§ÇØ ¾ÈÀüÇÑ È¯ÀÚ Ãë±ÞÀ» ½ÃÇàÇÏ´Â °ÍÀÇ Á߿伺À» ÀνÄÇϰí ÀÖ½À´Ï´Ù. Á¶Á÷µéÀº ÀûÀýÇÑ ¸®ÇÁÆÃ ±â¼ú°ú À̵¿ Áß º¸Á¶±â±¸ »ç¿ëÀ» ÃËÁøÇϱâ À§ÇÑ ±³À° ÇÁ·Î±×·¥ ¹× ÀÎü°øÇÐÀû Æò°¡¿¡ Á¡Á¡ ´õ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. Á¾ÇÕÀûÀÎ ¾ÈÀüÇÑ È¯ÀÚ Ãë±Þ ÇÁ·Î±×·¥À» ½ÃÇàÇÏ´Â ½Ã¼³¿¡¼­´Â Á÷¿ø ºÎ»ó·üÀÌ ³·À¸¸ç, 2023³â ¸Þµå¶óÀÎÀº ¹Ì±¹ ³» ÇコÄÉ¾î °ø±Þ¸ÁÀ» °­È­Çϱâ À§ÇØ À¯Åë, Á¦Á¶, Áö¼Ó°¡´É¼º¿¡ ÃÊÁ¡À» ¸ÂÃá ÇコÄɾî ȸº¹Åº·Â¼º ÀÌ´Ï¼ÅÆ¼ºê¿¡ 3¾ï ´Þ·¯¸¦ Ãß°¡ ÅõÀÚÇÒ ¿¹Á¤ÀÔ´Ï´Ù. Ãß°¡ ÅõÀÚÇß½À´Ï´Ù. ÀÌ·Î½á ¸Þµå¶óÀÎÀÇ ÃÑ ÅõÀÚ¾×Àº 20¾ï ´Þ·¯¿¡ À̸£·¶À¸¸ç, °í°´ ¼­ºñ½º Çâ»ó¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ³ë·ÂÀ» º¸¿©ÁÖ¾ú½À´Ï´Ù.

Àü ¼¼°è ±ÔÁ¦ ´ç±¹Àº ȯÀÚ¿Í °£º´ÀÎÀÇ ¾ÈÀüÀ» À§ÇØ ÀÇ·á ½Ã¼³¿¡ ÀûÀýÇÑ ÀÌ¼Û Àåºñ µµÀÔÀ» Àǹ«È­ÇÏ´Â °¡À̵å¶óÀÎÀ» ½ÃÇàÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±ÔÁ¦¸¦ µû¸£Áö ¾ÊÀ» °æ¿ì, ÀÇ·á±â°üÀº ¹úÄ¢À̳ª ¹ýÀû Á¶Ä¡¸¦ ¹ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹¿¡¼­´Â OSHA(Occupational Safety and Health Administration)¿Í °°Àº ±â°üÀÌ ÀÇ·á ȯ°æ¿¡¼­ÀÇ ¾ÈÀüÇÑ È¯ÀÚ Ãë±Þ ¿ä°Ç¿¡ ´ëÇÑ ±¸Ã¼ÀûÀÎ ±âÁØÀ» ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù. Midwest Medical Edition¿¡ µû¸£¸é, ¸®ÇÁÆÃ ÀåÄ¡ÀÇ µµÀÔÀº È¿°úÀûÀÎ ¾ÈÀüÇÑ È¯ÀÚ Ãë±Þ ÀÌ´Ï¼ÅÆ¼ºê¿¡ ÀÖ¾î ¸Å¿ì Áß¿äÇϸç, ÀÌ·¯ÇÑ ±ÔÁ¦´Â º´¿ø°ú Àå±â¿ä¾ç½Ã¼³ÀÌ ¾÷°è Ç¥ÁØÀ» ÁؼöÇϱâ À§ÇØ ÃÖ÷´Ü Ãø¸é À̵¿ ¼Ö·ç¼Ç¿¡ ÅõÀÚÇÏ´Â °è±â°¡ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ´Ï¼ÅÆ¼ºê¿¡ Áß¿äÇϸç, ¼öµ¿ ¸®ÇÁÆÃÀ¸·Î ÀÎÇÑ ºÎ»ó À§ÇèÀ» 95%±îÁö Å©°Ô ³·Ãâ ¼ö ÀÖ´Ù°í ÇÕ´Ï´Ù.

ȯÀÚ Ãø¸é À̵¿ ¼¼°è ½ÃÀå ¼¼ºÐÈ­ º¸°í¼­

ÀÌ º¸°í¼­´Â 2018³âºÎÅÍ 2030³â±îÁö ¼¼°è, Áö¿ª ¹× ±¹°¡º° ¼öÀÍ ¼ºÀåÀ» ¿¹ÃøÇÏ°í °¢ ÇÏÀ§ ºÎ¹®ÀÇ ÃֽŠ»ê¾÷ µ¿Çâ¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ Á¶»ç¿¡¼­ Grand View Research´Â ¼¼°è ȯÀÚ Ãø¸é À̵¿ ½ÃÀå º¸°í¼­¸¦ À¯Çü, »ç¿ë, ÃÖÁ¾ ¿ëµµ ¹× Áö¿ª¿¡ µû¶ó ´ÙÀ½°ú °°ÀÌ ¼¼ºÐÈ­Çß½À´Ï´Ù.

  • À¯Çüº° Àü¸Á(¸ÅÃâ¾×, 2018-2030³â)
  • ¿¡¾î ¾î½Ã½ºÆ® Æ®·£½ºÆÛ ¸ÅÆ®¸®½º

ÀÏ¹Ý ¸ÅÆ®¸®½º

½ºÇø´ ·¹±× ¸ÅÆ®¸®½º

ÇÏÇÁ ¸ÅÆ®¸®½º

  • ½½¶óÀÌµå ½ÃÆ®
  • ¾×¼¼¼­¸®
  • »ç¿ë Àü¸Á(¸ÅÃâ¾×, 2018-2030³â)
  • Àç»ç¿ë °¡´É
  • ÀÏȸ¿ë
  • ÃÖÁ¾ ¿ëµµ Àü¸Á(¸ÅÃâ¾×, 2018-2030³â)
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ ÃÖÁ¾ ¿ëµµ
  • Áö¿ªº° Àü¸Á(¸ÅÃâ¾×, 2018-2030³â)
  • ºÏ¹Ì

¹Ì±¹

ij³ª´Ù

¸ß½ÃÄÚ

  • À¯·´

µ¶ÀÏ

¿µ±¹

ÇÁ¶û½º

ÀÌÅ»¸®¾Æ

½ºÆäÀÎ

µ§¸¶Å©

½º¿þµ§

³ë¸£¿þÀÌ

  • ¾Æ½Ã¾ÆÅÂÆò¾ç

Áß±¹

ÀϺ»

Àεµ

Çѱ¹

È£ÁÖ

ű¹

  • ¶óƾ¾Æ¸Þ¸®Ä«

ºê¶óÁú

¾Æ¸£ÇîÆ¼³ª

  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

³²¾ÆÇÁ¸®Ä«°øÈ­±¹

»ç¿ìµð¾Æ¶óºñ¾Æ

UAE

Äí¿þÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ȯÀÚ Ãø¸é À̵¿ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/º¸Á¶ÀûÀÎ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå °ßÀÎ ¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ȯÀÚ Ãø¸é À̵¿ ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®
    • COVID-19ÀÇ ¿µÇ⠺м®

Á¦4Àå ȯÀÚ Ãø¸é À̵¿ ½ÃÀå : À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå À¯Çü º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, À¯Çüº°, 2018-2030³â
  • ¿¡¾î ¾î½Ã½ºÆ® Æ®·£½ºÆÛ ¸ÅÆ®¸®½º
  • ½½¶óÀÌµå ½ÃÆ®
  • ¾×¼¼¼­¸®

Á¦5Àå ȯÀÚ Ãø¸é À̵¿ ½ÃÀå : »ç¿ë ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå »ç¿ë º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ¿ëµµº°, 2018-2030³â
  • Àç»ç¿ë °¡´É
  • ÀÏȸ¿ë

Á¦6Àå ȯÀÚ Ãø¸é À̵¿ ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ¼¼°èÀÇ È¯ÀÚ Ãø¸é À̵¿ ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • º´¿ø
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ±âŸ ¿ëµµ

Á¦7Àå ȯÀÚ Ãø¸é À̵¿ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦8Àå °æÀï »óȲ

  • ±â¾÷/°æÀï ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • Arjo
    • Medline Industries, Inc.
    • AliMed
    • HoverTech International.
    • EZ Way Inc.
    • Haines Medical Australia
    • Patient Positioning Systems, LLC.
    • Stryker
    • Agiliti Health, Inc.
    • Wy'East Medical.
ksm 24.08.22

Patient Lateral Transfer Market Size & Trends

The global patient lateral transfer market size was estimated at USD 412.4 million in 2023 and is projected to expand at a CAGR of 9.1% from 2024 to 2030. The market is affected by several factors. The increasing prevalence of chronic diseases and disabilities is driving demand. Advancements in technology have led to the development of innovative transfer devices. There is also a rising awareness about the importance of safe patient handling practices. Furthermore, stringent regulations mandate the use of proper transfer equipment in healthcare settings.

The growing incidence of chronic diseases and disabilities worldwide has necessitated the need for efficient patient transfer solutions. Conditions such as obesity, musculoskeletal disorders, and neurological impairments often require specialized equipment for safe and comfortable lateral transfers. For instance, in March 2024, the World Health Organization reported that as of 2022, 1 in 8 people worldwide were living with obesity. Furthermore, out of 2.5 billion adults aged 18 and older who were overweight, 890 million were categorized as living with obesity. This rise in chronic conditions has fueled the demand for transfer aids that can ensure both patient comfort and caregiver safety.

Technological advancements have revolutionized the patient transfer market by enabling the development of sophisticated transfer devices that enhance efficiency and reduce the risk of injuries during transfers. Devices such as air-assisted lateral transfer systems, slide sheets, and mechanical lifts have significantly improved the ease and safety of moving patients. These innovations streamline healthcare workflows and contribute to better patient outcomes. In March 2022, Sage unveiled a new mobile air transfer system for operating rooms, the Multi-Position MATS. This device aims to ensure the safe positioning and transferring of patients by OR nurses, minimizing the risk of sliding and injuries in critical tilt positions like lithotomy, Trendelenburg, and more.

There is a growing recognition among healthcare providers about the importance of implementing safe patient handling practices to prevent musculoskeletal injuries among caregivers and ensure optimal patient care. Organizations increasingly invest in training programs and ergonomic assessments to promote proper lifting techniques and use of assistive devices during transfers. Facilities with comprehensive safe patient handling programs experience lower injury rates among staff members. In 2023, Medline invested an extra USD 300 million into its Healthcare Resilience Initiative to enhance the U.S. healthcare supply chain, focusing on distribution, manufacturing, and sustainability. This raises their total investment to USD 2 billion, demonstrating their ongoing commitment to improving customer service.

Regulatory bodies worldwide are enforcing guidelines that mandate healthcare facilities to implement appropriate transfer equipment to safeguard both patients and caregivers. Non-compliance with these regulations can result in penalties or legal consequences for institutions. For instance, in the U.S., agencies like OSHA (Occupational Safety and Health Administration) have specific standards addressing safe patient handling requirements in healthcare settings. Such regulations act as catalysts for hospitals and long-term care facilities to invest in state-of-the-art lateral transfer solutions to ensure compliance with industry standards. Based on information from Midwest Medical Edition, implementing lifting devices is critical for an effective safe patient-handling initiative, significantly lowering the risk of injuries from manual lifting by as much as 95%.

Global Patient Lateral Transfer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global patient lateral transfer market report based on type, usage, end use, and region:

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Air-assisted Transfer Mattress

Regular Mattress

Split-leg Mattress

Half Mattress

  • Slide Sheets
  • Accessories
  • Usage Outlook (Revenue, USD Million, 2018 - 2030)
  • Reusable
  • Disposable
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Use
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Usage
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Patient Lateral Transfer Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. The increasing prevalence of chronic diseases and disabilities
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. rising awareness about safe patient handling practices
      • 3.2.1.4. Stringent regulations
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High costs
      • 3.2.2.2. Regulatory standards
  • 3.3. Patient Lateral Transfer Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Patient Lateral Transfer Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Patient Lateral Transfer Market Type Movement Analysis
  • 4.3. Global Patient Lateral Transfer Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Air-assisted Transfer Mattress
    • 4.4.1. Air-assisted transfer mattress market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Regular Mattress
      • 4.4.2.1. Regular mattress market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Split-leg Mattress
      • 4.4.3.1. Split-leg mattress market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Half Mattress
      • 4.4.4.1. Half mattress market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Slide Sheets
    • 4.5.1. Slide sheets market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Accessories
    • 4.6.1. Accessories market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Patient Lateral Transfer Market: Usage Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Patient Lateral Transfer Market Usage Movement Analysis
  • 5.3. Global Patient Lateral Transfer Market Size & Trend Analysis, by Usage, 2018 to 2030 (USD Million)
  • 5.4. Reusable
    • 5.4.1. Reusable market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Disposable
    • 5.5.1. Disposable market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Patient Lateral Transfer Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Patient Lateral Transfer Market End Use Movement Analysis
  • 6.3. Global Patient Lateral Transfer Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Surgical Centers
    • 6.5.1. Ambulatory surgical centers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Other End Use
    • 6.6.1. Other end use market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Patient Lateral Transfer Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis
  • 8.4. Company Profiles/Listing
    • 8.4.1. Arjo
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medline Industries, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. AliMed
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. HoverTech International.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. EZ Way Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Haines Medical Australia
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Patient Positioning Systems, LLC.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Stryker
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Agiliti Health, Inc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Wy'East Medical.
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Type benchmarking
      • 8.4.10.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦